About Hereditary Hemorrhagic Telangiectasia (HHT) ‍HHT is a rare disease that affects more than 150,000 people in the U.S. and EU, and for which there are currently no approved therapies.

WATERTOWN, Mass., June 18, 2025 (GLOBE NEWSWIRE) -- Diagonal Therapeutics, a biotechnology company focused on correcting dysregulated signaling with clustering antibodies that address the underlying ...

As previously reported at the annual meeting of the American Academy of Allergy, Asthma & Immunology and published in The Lancet in 2023, garadacimab reduced investigator-confirmed HAE attacks by ...

A "potential microbial contamination " has lead to the recall of several cold nasal swabs and baby teething swabs, according to an announcement from the U.S. Food and Drug Administration June 9.

The patient had used a nasal irrigation device (not pictured) filled with unboiled tap water from an RV’s water faucet. (iStock) "The risk of brain-eating amoeba is very low," she said.

A 71-year-old Texas woman died from a rare brain infection linked to a nasal rinse. She developed severe neurological symptoms after using untreated water from an RV at a campground.

Unlike older drugs for hereditary angioedema designed to treat swelling once it happens, Andembry was created to prevent attacks from happening in the first place. The new drug blocks a protein ...

Swabs with contamination can be a significant risk to health and safety, including life-threatening blood infections in users with compromised nasal mucosa, Church & Dwight said.

Zicam Cold Remedy Nasal Swabs, with UPC 732216301205, all lots Zicam Nasal AllClear Swabs, with UPC 732216301656, all lots Orajel™ Baby Teething Swabs, with UPC 310310400002, all lots ...

Texas woman dies from brain-eating amoeba after using tap water in nasal rinse The woman used tap water from an RV to rinse her sinuses, leading to a rare and often fatal brain infection caused by ...

For people diagnosed with macular telangiectasia type 2 (MacTel)-a rare and slowly progressing retinal disease-there have been no FDA-approved (or other) treatments to slow or stop vision loss.